Company intelligence / Profile preview

Medsyn Lab Biotech

Ownership: Private
Development stage: Preclinical

Overview

Medsyn Lab Biotech is an ISO 9001:2015 certified Indian pharmaceutical company focused on the manufacture and marketing of high-quality, WHO-GMP certified generic medicines. The company operates as a third-party manufacturer and franchise provider, supplying a broad range of cost-effective pharma products to clients across India. No specific clinical trial results are reported; the business model centers on commercial supply rather than novel drug development.

Therapeutic areas: Other
Modalities: Small moleculeGeneric drugs
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

BR0063

Pre-clinical

Indications: Solid tumors

Beyond the preview

Go deeper on Medsyn Lab Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medsyn Lab Biotech.

Explore the full profile